BioHarvest Sciences Inc.
BHST
$11.04
-$0.99-8.23%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | 25.67% | 52.86% | -2.78% | -111.33% | -57.08% |
Total Depreciation and Amortization | 51.01% | 71.56% | 48.93% | 37.99% | 25.09% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -57.48% | -92.20% | 126.11% | 751.09% | 105,225.00% |
Change in Net Operating Assets | -117.07% | 86.09% | -173.51% | -167.09% | 7,275.00% |
Cash from Operations | -7.75% | 22.64% | 21.57% | 9.25% | 31.57% |
Capital Expenditure | 18.04% | -149.77% | -92.33% | -89.00% | -107.08% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 116.44% | -- | -- | -- | -- |
Cash from Investing | 25.71% | -164.02% | -105.36% | -101.80% | -124.59% |
Total Debt Issued | 11.01% | -48.06% | -75.48% | -19.04% | -21.56% |
Total Debt Repaid | -246.65% | -232.68% | -249.45% | -40.62% | -25.14% |
Issuance of Common Stock | -100.00% | 1,035.82% | 1,075.68% | 1,072.77% | 317.81% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -38.51% | -21.87% | -49.99% | 29.13% | 10.95% |
Foreign Exchange rate Adjustments | -175.29% | -144.87% | -157.63% | 723.08% | 808.33% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -142.94% | -101.12% | -181.93% | 269.57% | 461.20% |